FDA recognizes database as reliable resource for genetic test developers
The Food and Drug Administration is blessing a public database for use by genetic test developers that are submitting premarket submissions. The agency says the database is recognized as a source of valid scientific evidence that now can be used by developers of genetic tests to support clinical validity in premarket submissions to the agency.… Read More »